Ascendis Pharma A/S (ASND)
210.16
+8.92
(+4.43%)
USD |
NASDAQ |
Dec 11, 16:00
211.00
+0.84
(+0.40%)
Pre-Market: 09:07
Ascendis Pharma Free Cash Flow: -123.89M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Evaxion AS | -- |
| Novo Nordisk A/S | 9.245B |
| DBV Technologies SA | -98.65M |
| Cellectis SA | -34.73M |
| Biodexa Pharmaceuticals Plc | -14.30M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.568M |
| Cash from Investing (Quarterly) | -0.2594M |
| Cash from Financing (Quarterly) | 43.34M |
| Free Cash Flow Per Share (Quarterly) | 0.0215 |
| Free Cash Flow to Equity (Quarterly) | -24.41M |
| Free Cash Flow to Firm (Quarterly) | 85.16M |
| Free Cash Flow Yield | -0.98% |